Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins

被引:35
作者
Bonneau, S
Vever-Bizet, C
Morlière, P
Mazière, JC
Brault, D
机构
[1] Museum Natl Hist Nat, CNRS, UMR 8646, Lab Photobiol, F-75231 Paris 05, France
[2] Hop St Louis, INSERM, U532, Inst Rech Peau, F-75475 Paris 10, France
[3] Hop Nord Amiens, Serv Biochim, F-80054 Amiens 01, France
关键词
D O I
10.1016/S0006-3495(02)75346-0
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Low-density lipoproteins (LDL) play a key role in the delivery of photosensitizers to tumor cells in photodynamic therapy. The interaction of deuteroporphyrin, an amphiphilic porphyrin, with LDL is examined at equilibrium and the kinetics of association/dissociation are determined by stopped-flow. Changes in apoprotein and porphyrin fluorescence suggest, two classes of bound porphyrins. The first class, characterized by tryptophan fluorescence quenching, involves four well-defined sites. The affinity constant per site is 8.75 X 10(7) M-1 (cumulative affinity 3.5 X 10(8) M-1). The second class corresponds to the incorporation of up to 50 molecules into the outer lipidic layer of LDL with an affinity constant of 2 X 10(8) M-1. Stopped-flow experiments involving direct LDL porphyrin mixing or porphyrin transfer from preloaded LDL to albumin provide kinetic characterization of the two classes. The rate constants for dissociation of the first and second classes are 5.8 and 15 s(-1); the association rate constants are 5 X 10(8) M-1 s(-1) per site and 3 X 10(9) M-1 s(-1), respectively. Both fluorescence and kinetic analysis indicate that the first class involves regions at the boundary between lipids and the apoprotein. The kinetics of porphyrin-LDL interactions indicates that changes in the distribution of photosensitizers among various carriers could be very sensitive to the specific tumor microenvironment.
引用
收藏
页码:3470 / 3481
页数:12
相关论文
共 44 条
[31]   PHOTODYNAMIC THERAPY OF EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION USING LIPOPROTEIN-DELIVERED BENZOPORPHYRIN [J].
MILLER, JW ;
WALSH, AW ;
KRAMER, M ;
HASAN, T ;
MICHAUD, N ;
FLOTTE, TJ ;
HAIMOVICI, R ;
GRAGOUDAS, ES .
ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (06) :810-818
[32]   THE BINDING OF DIHEMATOPORPHYRIN ETHER (PHOTOFRIN-II) TO HUMAN-SERUM ALBUMIN [J].
MOAN, J ;
RIMINGTON, C ;
WESTERN, A .
CLINICA CHIMICA ACTA, 1985, 145 (03) :227-236
[33]   PHOTODYNAMIC THERAPY IN ONCOLOGY - MECHANISMS AND CLINICAL USE [J].
PASS, HI .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (06) :443-456
[35]   Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting [J].
Rensen, PCN ;
de Vrueh, RLA ;
Kuiper, J ;
Bijsterbosch, MK ;
Biessen, EAL ;
van Berkel, TJC .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :251-276
[36]   INTERACTION OF HUMAN-SERUM LOW-DENSITY LIPOPROTEINS WITH PORPHYRINS - A SPECTROSCOPIC AND PHOTOCHEMICAL STUDY [J].
REYFTMANN, JP ;
MORLIERE, P ;
GOLDSTEIN, S ;
SANTUS, R ;
DUBERTRET, L ;
LAGRANGE, D .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1984, 40 (06) :721-729
[37]  
RUDLING MJ, 1983, CANCER RES, V43, P4600
[38]   Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates [J].
SchmidtErfurth, U ;
Diddens, H ;
Birngruber, R ;
Hasan, T .
BRITISH JOURNAL OF CANCER, 1997, 75 (01) :54-61
[39]  
SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205
[40]  
Segrest JP, 2001, J LIPID RES, V42, P1346